Many signaling pathways participate in both synaptic plasticity and neuronal degeneration. While calpains participate in these phenomena, very few studies have evaluated the respective roles of the two major calpain isoforms in the brain, calpain-1 and calpain-2. We review recent studies indicating that calpain-1 and calpain-2 exhibit opposite functions in both synaptic plasticity and neurodegeneration. Calpain-1 activation is required for the induction of long-term potentiation (LTP) and is generally neuroprotective, while calpain-2 activation limits the extent of potentiation and is neurodegenerative. This duality of functions is related to their associations with different PDZ-binding proteins, resulting in differential subcellular localization, and offers new therapeutic opportunities for a number of indications in which these proteases have previously been implicated.
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Common Pathways in Synaptic Plasticity and Neurodegeneration
All cells in multicellular organisms have to perform a number of basic functions: to reproduce, grow, migrate, respond, and adapt to external stimuli, and to survive (or die). Not surprisingly, these functions require a large number of housekeeping genes and regulatory systems. Neurons share all these functions, with the exception of reproduction, and face the additional challenge that they need to be better able to respond and adapt to a wide array of internal and external signals, and to survive despite multiple insults and the deleterious effects of the aging process [1]. Furthermore, neurons had to evolve adaptations of these mechanisms in specialized cell compartments needed for neuronal communication, the synapses. Thus, neuronal and synaptic plasticity, the ability of neurons or synapses to adapt to changes in the environment, and neuronal survival or death, that is, neurodegeneration, are processes that have evolved in parallel using the cellular machinery involved in basic cellular physiological functions, including gene regulation, cytoskeletal adaptation, and neuronal survival/apoptosis [2] . Numerous studies indicate that synaptic plasticity and neurodegeneration are indeed two sides of the same coin, and that many signaling pathways are involved in both synaptic plasticity and learning and memory and in synaptic dysfunction and neurodegeneration [3] [4] [5] . These pathways, including histone acetylation and deacetylation [6] [7] [8] , , and mTOR signaling [13, 14] , are implicated in gene regulation, local protein translation and degradation, as well as in cytoskeletal remodeling. This review will focus on a signaling pathway, the calpain system, which was previously shown to be crucial for cell motility and cell division. It appears that this pathway has been adapted through evolution to play a major role in both synaptic plasticity and neuronal survival/neurodegeneration Trends Several signaling pathways are involved in both synaptic plasticity and neurodegeneration.
Calpain-1 and calpain-2 have opposite functions in synaptic plasticity and neurodegeneration due to their associations with different downstream signaling cascades.
Calpain-2 couples local protein synthesis and degradation, which play crucial roles in both synaptic plasticity and neurodegeneration.
These mechanisms offer new targets for therapeutic approaches to diseases associated with learning impairment and neurodegeneration.
